Regression stage senile plaques in the natural course of Alzheimer's disease

Neuropathology and Applied Neurobiology

Volumn 32, Issue 5, 2006, Pages 539-556

  Oide, T ^a,b,c   Kinoshita, T ^d   Arima, K ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d Kodama Clinic   (Japan)

Author keywords

Alzheimer's disease; Amyloid protein (A ); Astrocyte; Remnant plaque; Removal process; Senile plaque

Indexed keywords

AMYLOID BETA PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CELL COUNT; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MACROGLIA; MALE; NEURITE; PRIORITY JOURNAL; REMISSION; SENILE PLAQUE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ALZHEIMER VACCINES; AMYLOID BETA-PROTEIN; AMYLOID NEUROPATHIES; ASTROCYTES; CYTOPLASMIC GRANULES; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MICROSCOPY, ELECTRON; MIDDLE AGED; NEUROFIBRILLARY TANGLES; NEUROGLIA; SENILE PLAQUES;

EID: 33748757401     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2006.00767.x     Document Type: Article

References (54)

1. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001; 81: 741-66
2. Hamill RW, Markesbery WR, McDaniel K, Coleman PD. Characterization of brain samples in studies of aging, Alzheimer's disease and other neurodegenerative diseases. Neurobiol Aging 1993; 14: 539-45
3. Tekirian TL, Saido TC, Markesbery WR, Russell MJ, Wekstein DR, Patel E, Geddes JW. N-terminal heterogeneity of parenchymal and cerebrovascular Aβ deposits. J Neuropathol Exp Neurol 1998; 57: 76-94
4. Dickson TC, Vickers JC. The morphological phenotype of β-amyloid plaques and associated neuritic changes in Alzheimer's disease. Neuroscience 2001; 105: 99-107
5. Mirra SS, Hyman BT. Aging and dementia. In: Greenfield's Neuropathology, 7th edn. Eds DI Graham, PL Lantos. London: Arnold, 2002; 195-262
6. Dickson DW. The pathogenesis of senile plaques. J Neuropathol Exp Neurol 1997; 56: 321-39
7. Ikeda S, Yanagisawa N, Allsop D, Glenner GG. Early senile plaques in Alzheimer's disease demonstrated by histochemistry, immunocytochemistry, and electron microscopy. Hum Pathol 1990; 21: 1221-6
8. Kuo YM, Webster S, Emmerling MR, De Lima N, Roher AE. Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of Aβ peptides of Alzheimer's disease. Biochim Biophys Acta 1998; 1406: 291-8
9. Nordstedt C, Näslund J, Tjernberg LO, Karlström AR, Thyberg J, Terenius L. The Alzheimer Aβ peptide develops protease resistance in association with its polymerization into fibrils. J Biol Chem 1994; 269: 30773-6
10. Soto C, Castaño EM. The conformation of Alzheimer's β peptide determines the rate of amyloid formation and its resistance to proteolysis. Biochem J 1996; 314: 701-7
11. Arriagada PV, Growdon JH, Hedley-Whyte T, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992; 42: 631-9
12. Mackenzie IRA. Senile plaques do not progressively accumulate with normal aging. Acta Neuropathol 1994; 87: 520-5
13. Hyman BT, Marzloff K, Arriagada PV. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J Neuropathol Exp Neurol 1993; 52: 594-600
14. Carson JA, Turner AJ. β-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases? J Neurochem 2002; 81: 1-8
15. Shaffer LM, Dority MD, Gupta-Bansal R, Frederickson RC, Younkin SG, Brunden KR. Amyloid β protein (Aβ) removal by neuroglial cells in culture. Neurobiol Aging 1995; 16: 737-45
16. Vinores SA, Herman MM. Phagocytosis of myelin by astrocytes in explants of adult rabbit cerebral white matter maintained on Gelfoam matrix. J Neuroimmunol 1993; 43: 169-76
17. Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P, Heslin D, French J, Mount HTJ, Nixon RA, Mercken M, Bergeron C, Fraser PE, St George-Hyslop P, Westaway D. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 2000; 408: 979-82
18. Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Conner K, Hatcher J, Hope C, Gordon M, Arendash GW. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 2000; 408: 982-5
19. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999; 400: 173-7
20. Nicoll JAR, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO. Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nat Med 2003; 9: 448-52
21. Ferrer I, Rovira MB, Guerra MLS, Rey MJ, Costa-Jussá F. Neuropathology and pathogenesis of encephalitis following amyloid-β immunization in Alzheimer's disease. Brain Pathol 2004; 14: 11-20
22. Funato H, Yoshimura M, Yamazaki T, Saido TC, Ito Y, Yokofujita J, Okeda R, Ihara Y. Astrocytes containing amyloid β-protein (Aβ)-positive granules are associated with Aβ40-positive diffuse plaques in the aged human brain. Am J Pathol 1998; 152: 983-92
23. Yamaguchi H, Sugihara S, Ogawa A, Saido TC, Ihara Y. Diffuse plaques associated with astroglial amyloid β protein, possibly showing a disappearing stage of senile plaques. Acta Neuropathol 1998; 95: 217-22
24. Hepper FL, Gandy S, McLaurin J. Current concepts and future prospects for Alzheimer disease vaccines. Alzheimer Dis Assoc Disord 2004; 18: 38-43
25. Matsunaga W, Shirokawa T, Isobe K. Specific uptake of Aβ1-40 in rat brain occurs in astrocyte, but not in microglia. Neurosci Lett 2003; 342: 129-31
26. Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F, Silverstein SC, Husemann J. Adult mouse astrocytes degrade amyloid-β in vitro and in situ. Nat Med 2003; 9: 453-7
27. Oyanagi S. On the ultrastructural aspect of senile plaques. Shinkei Kenkyu No Shinpo 1990; 34: 350-65
28. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-44
29. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-59
30. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-86
31. Kitamoto T, Ogomori K, Tateishi J, Prusiner SB. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 1987; 57: 230-6
32. Lan HY, Mu W, Nikolic-Paterson DJ, Atkins RC. A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J Histochem Cytochem 1995; 43: 97-102
33. Saito Y, Ruberu NN, Harada M, Arai T, Sawabe M, Nukina N, Murayama S. In situ detection of apolipoprotein E ε 4 in archival human brain. Neuroreport 2004; 15: 1113-15
34. Neary D, Snowden JS, Mann DMA, Bowen DM, Sims NR, Northen B, Yates PO, Davison AN. Alzheimer's disease: a correlative study. J Neurol Neurosurg Psychiatry 1986; 49: 229-37
35. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30: 572-80
36. Wegiel J, Wísniewski HM, Morys J, Tarnawski M, Kuchna I, Dziewiatkowski J, Pirttilä T, Krivimäki T, Lehtimäki T, Lach B. Neuronal loss and β-amyloid removal in the amygdala of people with Down syndrome. Neurobiol Aging 1999; 20: 259-69
37. DeMattos RB, Bales KR, Cummins DJ, Dodart JC, Paul SM, Holtzman DM. Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decrease brain Aβ burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2001; 98: 8850-5
38. Games D, Bard F, Grajeda H, Guido T, Khan K, Soriano F, Vasquez N, Wehner N, Johnson-Wood K, Yednock T, Seubert P, Schenk D. Prevention and reduction of AD-type pathology in PDAPP mice immunized with Aβ1-42. Ann N Y Acad Sci 2000; 920: 274-84
39. Hock C, Konietzko U, Streffer JR, Tracy J, Signorell A, Müller-Tillmanns B, Lemke U, Henke K, Moritz E, Garcia E, Wollmer MA, Umbricht D, de Quervain DJF, Hofmann M, Maddalena A, Papassotiropoulos A, Nitsch RM. Antibodies against β-amyloid slow cognitive decline in Alzheimer's disease. Neuron 2003; 38: 547-54
40. Orgogozo JM, Gilman S, Dartigues JF, Laurent B, Puel M, Kirby LC, Jouanny P, Dubois B, Eisner L, Flitman S, Michel BF, Boada M, Frank A, Hock C. Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization. Neurology 2003; 61: 46-54
41. Schenk D. Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning. Nat Rev Neurosci 2002; 2: 824-8
42. Ard MD, Cole GM, Wei J, Mehrle AP, Fratkin JD. Scavenging of Alzheimer's amyloid β-protein by microglia in culture. J Neurosci Res 1996; 43: 190-202
43. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 2000; 6: 916-19
44. El Khoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature 1996; 382: 716-19
45. Nakagawa Y, Reed L, Nakamura M, McIntosh TK, Smith DH, Saatman KE, Raghupathi R, Clemens J, Saido TC, Lee VMY, Trojanowski JQ. Brain trauma in aged transgenic mice induces regression of established Aβ deposits. Exp Neurol 2000; 163: 244-52
46. Paresce DM, Ghosh RN, Maxfield FR. Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron 1996; 17: 553-65
47. Motte J, Williams RS. Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain. Acta Neuropathol 1989; 77: 535-46
48. Akiyama H, Mori H, Saido T, Kondo H, Ikeda K, McGeer PL. Occurrence of the diffuse amyloid β-protein (Aβ) deposits with numerous Aβ-containing glial cells in the cerebral cortex of patients with Alzheimer's disease. Glia 1999; 25: 324-31
49. Akiyama H, Schweb C, Kondo H, Kametani F, Ikeda K, McGeer PL. Granules in glial cell of patients with Alzheimer's disease are immunopositive for C-terminal sequences of β-amyloid protein. Neurosci Lett 1996; 206: 169-72
50. Kurt MA, Davies DC, Kidd M. β-amyloid immunoreactivity in astrocytes in Alzheimer's disease brain biopsies: an electron microscope study. Exp Neurol 1999; 158: 221-8
51. Al-Ali SY, Al-Hussain SM. An ultrastractural study of the phagocytotic activity of astrocytes in adult rat brain. J Anat 1996; 188: 257-62
52. Bechmann I, Nitsch R. Astrocytes and microglial cells incorporate degenerating fibers following entorhinal lesion: a light, confocal, and electron microscopical study using a phagocytosis-dependent labeling technique. Glia 1997; 20: 145-54
53. Fountain NB, Eberhard DA. Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Report of two cases and review of the literature. Neurology 1996; 46: 190-7
54. Oide T, Tokuda T, Takei Y, Takahashi H, Ito K, Ikeda S. Serial CT and MRI findings in a patient with isolated angiitis of the central nervous system associated with cerebral amyloid angiopathy. Amyloid 2002; 9: 256-62